GlassScriptPhysician profile
Karina Torres
NPI 1417476078
$4,651.36
in general payments reported to CMS, 2019-2025
20 companies · $3,593 in 2025
The $3,593 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $241 · 2022: $147 · 2023: $88.86 · 2024: $580 · 2025: $3,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,103 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,102.60 |
| Education | $159.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $818.43 | 2021-2025 | Tremfya |
| Abbvie INC. | $579.13 | 2021-2025 | |
| Pfizer INC. | $495.45 | 2024-2025 | |
| Genzyme Corporation | $369.04 | 2024-2025 | |
| Lilly USA, LLC | $339.29 | 2024-2025 | Ebglyss, Taltz |
| Regeneron Healthcare Solutions, INC. | $329.22 | 2024-2025 | Dupixent |
| Galderma Laboratories, L.P. | $317.86 | 2025 | Nemluvio |
| Incyte Corporation | $265.52 | 2024-2025 | Opzelura, Opzelura |
| Arcutis Biotherapeutics, INC. | $255.87 | 2025 | Zoryve |
| Journey Medical Corporation | $234.62 | 2025 | Emrosi |
| Organon LLC | $193.43 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $175.04 | 2025 | |
| Dermavant Sciences, INC. | $108.97 | 2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $41.62 | 2021 | |
| Amgen INC. | $35.28 | 2024-2025 | Otezla, Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.71 | 2025 | Spevigo |
| Cipher Pharmaceuticals US LLC | $28.28 | 2025 | Natroba, Spinosad |
| Gilead Sciences, INC. | $15.54 | 2021 | |
| Chiesi USA, INC. | $14.79 | 2022 | |
| Mayne Pharma Commercial LLC | $5.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karina Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.